CYP2C8, SLCO1B1 Variants Impact Response to Rosiglitazone Physician's Briefing, 10 Jun 2016 (HealthDay News) -- Genetic variants in CYP2C8 and SLCO1B1 impact the therapeutic response to rosiglitazone in patients with…